Haloperidol treatment decreases nerve growth factor levels in the hypothalamus of adult mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 3, 1996, Pages 483-489

  Alleva, Enrico ^a   Seta, Daniele Della ^a,b   Cirulli, Francesca ^a   Aloe, Luigi ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

Author keywords

CNS; Haloperidol; Hypothalamus; NGF; Stress

Indexed keywords

HALOPERIDOL; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; DRUG DOSE; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; STRESS;

EID: 0029951484     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(96)00010-3     Document Type: Article

References (25)

1. ALBERCH, J., BRITO, B., NOTARIO, V. and CASTRO, R. (1991) Prenatal haloperidol treatment decreases nerve growth factor receptor and mRNA in neonate rat forebrain. Neurosci. Lett. 131: 228-232.
2. ALLEVA, E. and ALOE, L. (1989) Physiological roles of NGF in adult rodents: a biobehavioral perspective. Int. J. Comp. Psychol. 2: 147-163.
3. ALOE, L. (1987) Intracerebral pretreatment with nerve growth factor prevents irreversible brain lesions in neonatal rats injected with iboteic acid. Biotechnology 5: 1085-1086.
4. ALOE, L., ALLEVA, E. and DE SIMONE, R. (1990) Changes of NGF level in mouse hypothalamus following intermale aggressive behavior: biological and immunohistochemical evidence. Behav. Brain Res. 39: 53-61.
5. ALOE, L., ALLEVA, E., BRACCI-LAUDERIO, L., DE SIMONE, R. and TALAMINI, L. (1992) NGF and NGF receptor localization in the hypothalamus of adult rodents. Abstract Second International Conference of China on Anatomical Sciences.
6. ALOE, L., BRACCI-LAUDIERO, L. and TIRASSA, P. (1993) The effects of chronic ethanol intake on brain NGF level and on NGF-target tissue of adult mice. Drug Alcohol Depend. 31: 159-167.
7. ALOE, L., TIRASSA, P. and ALLEVA, E. (1994) Cold water swimming stress alters NGF and low-affinity NGF receptor distribution in developing rat brain. Brain Res. Bull. 33: 173-178.
8. BALDESSARINI, R. J. (1992) In: The Pharmacological basis of therapeutics, A. Goodman Gilman, L. S. Goodman, T. W. Rall and F, Murad (Eds.), pp 387-445, Macmillan Publishing Company, New York.
9. BRACCI-LAUDIERO, L., ALOE, L., LEVI-MONTALCINI, R., GALEAZZI, M., SCHILTER, D., SCULLY, J.L. and OTTEN, U. (1993) Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport 4: 563-565.
10. FURUKAWA, Y., FUKAZAWA, N., MIYAMA, Y., HAYASHI, K. and FURUKAWA, S. (1990) Stimulatory effect of 4-alkylcatechols and their diacetylated derivatives on the synthesis of nerve growth factor. Biochem. Pharmacol. 40: 2337-2342.
11. GALL, C. M. and ISACKSON, P. J. (1989) Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 245: 758-761.
12. HEUMANN, R., KORSCHING, S., BANDTLOW, H. and THOENEN, H. (1987) Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection. J. Cell Biol. 104: 1623-1631.
13. LEVI-MONTALCINI, R., ALOE, L. and ALLEVA, E. (1990) A role for nerve growth factor in nervous, endocrine and immune systems. Prog. Neuroendocrinlmmunol. 3: 1-10.
14. LEVI-MONTALCINI, R. (1987) The nerve growth factor: Thirty-five years later. Science 237: 1154-1162.
15. LUPPI, P., LEVI-MONTALCINI, R., BRACCI-LAUDIERO, L., BERTOLINI, A., ARLETTI, R., TAVERNARI, D., VIGNETI, E. and ALOE, L. (1993) NGF is released into plasma during human pregnancy: an oxytocin-mediated response?. Neuroreport 4: 1063-1065.
16. MINAMI, M., KURAISHI, Y., YAMAGUCHI, T., NAKAI, S., HIRAI, Y. and SATOH, M. (1991) Immobilization stress induces interleukin-1β mRNA in the rat hypothalamus. Neurosci. Lett. 123: 254-256.
17. NITTA, A., FURUKAWA, Y., HAYASHI, K., HIRAMATSU, M., KAMEYAMA, T., HASEGAWA, T. and NABESHIMA, T. (1992) Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci. Lett. 144: 152-156.
18. OTTEN, U., BAUMANN, J. B. and GIRARD, J. (1979) Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature 282: 413-414.
19. RIVEST, S., TORRES, G. and RIVIER, C. (1992) Differential effects of central and peripheral injection of interleukin-1β on brain c-fos expression and neuroendocrine functions. Brain. Res. 587: 13-23.
20. SAGRATELLA, S., SCOTTI DE CAROLIS, A., PEZZOLA, A. and POPOLI, P. (1991) Behavioral and electroencephalographic interactions between haloperidol and PCP/sigma ligands in the rat. Psychopharmacology 105: 485-491.
21. SPILLANTINI, M. G., ALOE, L., ALLEVA, E., DE SIMONE, R., GOEDERT, M. and LEVI-MONTALCINI, R. (1989) Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. PNAS 86: 8555-8559.
22. SPRANGER, M., LINDHOLM, D., BANDTLOW, C., HEUMANN, R., GNAHN, H., NOE, M.N. and THOENEN, H. (1990) Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of Interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2: 69-76.
23. STORK, O., HASHIMOTO, T. and OBATA, K. (1994) Haloperidol activates tyrosine hydroxylase gene-expression in the rat substantia nigra, pars reticulata. Brain Res. 633: 213-222.
24. TIRASSA, P., and ALOE, L. (1993) Intravenous injection of monosodium-glutamate causes NGF decrease in the hypothalamus and increases in blood serum. Abstract 2nd Int. Congress ISNIM Paestum.
25. WESKAMP, G. and OTTEN, U. (1987) An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J. Neurochem. 48: 1779-1786.